Variant report

Variant	esv3435148
Chromosome Location	chr2:11622251-11624149
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:40)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:40 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:77905046..77907139-chr2:11621088..11623747,2	MCF-7	breast:
2	chr2:11263419..11265242-chr2:11621241..11623957,2	MCF-7	breast:
3	chr2:11583321..11585484-chr2:11620633..11622396,2	MCF-7	breast:
4	chr2:11621457..11624787-chr2:11753040..11757547,4	MCF-7	breast:
5	chr2:11373517..11376626-chr2:11621500..11624054,4	MCF-7	breast:
6	chr2:11622407..11624543-chr2:228505560..228507680,2	MCF-7	breast:
7	chr17:57922980..57925938-chr2:11621191..11623045,2	MCF-7	breast:
8	chr2:11295276..11298034-chr2:11619894..11623397,3	MCF-7	breast:
9	chr2:11621665..11625691-chr2:11759993..11762950,4	MCF-7	breast:
10	chr2:10968173..10970876-chr2:11621344..11624039,2	MCF-7	breast:
11	chr17:59486452..59489829-chr2:11621116..11624500,4	MCF-7	breast:
12	chr2:11620752..11623461-chr7:108208476..108211188,2	MCF-7	breast:
13	chr16:72323629..72325628-chr2:11623411..11625010,2	MCF-7	breast:
14	chr2:11567153..11569270-chr2:11621893..11624749,2	MCF-7	breast:
15	chr2:11622883..11625359-chr2:11804160..11807192,3	MCF-7	breast:
16	chr2:11622300..11624024-chr2:11961134..11963850,2	MCF-7	breast:
17	chr2:11621442..11624193-chr6:27859669..27862456,2	MCF-7	breast:
18	chr2:11272161..11273870-chr2:11621396..11624363,2	MCF-7	breast:
19	chr2:11267451..11270365-chr2:11623207..11626147,3	MCF-7	breast:
20	chr2:11623822..11624579-chr5:160607967..160608472,2	MCF-7	breast:
21	chr2:11620780..11623645-chr2:11748441..11751021,2	MCF-7	breast:
22	chr17:56736452..56738278-chr2:11622249..11624597,2	MCF-7	breast:
23	chr1:40041963..40043870-chr2:11623878..11625841,2	MCF-7	breast:
24	chr2:11623545..11625174-chr5:160606467..160607967,2	MCF-7	breast:
25	chr2:11620928..11624804-chr20:45948428..45951214,3	MCF-7	breast:
26	chr2:11620854..11623036-chr5:41911701..41913647,2	MCF-7	breast:
27	chr2:11619575..11623223-chr2:11785570..11788850,5	MCF-7	breast:
28	chr2:11622770..11625345-chr2:11826653..11829595,2	MCF-7	breast:
29	chr2:11623292..11624131-chr2:11679829..11680570,2	MCF-7	breast:
30	chr2:11620802..11622693-chr2:11801885..11804962,3	MCF-7	breast:
31	chr2:11572499..11575442-chr2:11621165..11623225,2	MCF-7	breast:
32	chr11:77899272..77902143-chr2:11623062..11626037,2	MCF-7	breast:
33	chr2:11268656..11272146-chr2:11621524..11625212,4	MCF-7	breast:
34	chr2:11621397..11624240-chr2:11808602..11811433,2	MCF-7	breast:
35	chr2:11484534..11486427-chr2:11621929..11623752,2	MCF-7	breast:
36	chr2:11313501..11315110-chr2:11621698..11623847,2	MCF-7	breast:
37	chr2:11623637..11624377-chr5:160607950..160608471,2	MCF-7	breast:
38	chr2:11260073..11263283-chr2:11621139..11624937,6	MCF-7	breast:
39	chr2:11620746..11622950-chr6:35997193..35998902,2	MCF-7	breast:
40	chr2:11619432..11626810-chr2:11815160..11825829,15	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000150873	chromatin interactions
ENSG00000118369	chromatin interactions
ENSG00000169006	chromatin interactions
ENSG00000145063	chromatin interactions
ENSG00000177683	chromatin interactions
ENSG00000196331	chromatin interactions
ENSG00000201524	chromatin interactions
ENSG00000128590	chromatin interactions
ENSG00000090621	chromatin interactions
ENSG00000230044	chromatin interactions
ENSG00000187013	chromatin interactions
ENSG00000233224	chromatin interactions
ENSG00000188997	chromatin interactions
ENSG00000134318	chromatin interactions
ENSG00000134324	chromatin interactions
ENSG00000202077	chromatin interactions
ENSG00000228496	chromatin interactions
ENSG00000162976	chromatin interactions
ENSG00000267280	chromatin interactions
ENSG00000197153	chromatin interactions
ENSG00000135241	chromatin interactions
ENSG00000207267	chromatin interactions
ENSG00000196208	chromatin interactions

Extended variants
information (count: 88 )
Associated
traits (count: 61 )

Variant overlapped rSNPs/rCNVs (count:88 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs555038358	chr2:11622304-11622305	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
2	rs573181180	chr2:11622340-11622341	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
3	rs113803891	chr2:11622342-11622343	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
4	rs540616681	chr2:11622374-11622375	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
5	rs114197603	chr2:11622381-11622382	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
6	rs577377528	chr2:11622391-11622392	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
7	rs544366929	chr2:11622443-11622444	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
8	rs563067247	chr2:11622462-11622463	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
9	rs11675074	chr2:11622497-11622498	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers	Chromatin interactive region	18 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs542303690	chr2:11622570-11622571	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
11	rs75357021	chr2:11622605-11622606	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
12	rs528039547	chr2:11622611-11622612	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
13	rs546587441	chr2:11622613-11622614	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
14	rs571484383	chr2:11622644-11622645	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
15	rs1109098	chr2:11622668-11622669	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs536306493	chr2:11622676-11622677	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
17	rs569059539	chr2:11622726-11622727	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
18	rs536784864	chr2:11622734-11622735	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
19	rs3893103	chr2:11622742-11622743	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs566759024	chr2:11622774-11622775	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
21	rs375209842	chr2:11622794-11622795	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
22	rs4276001	chr2:11622808-11622809	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs4330088	chr2:11622868-11622869	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
24	rs577439734	chr2:11622945-11622946	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	19 gene(s)	Overlapped CNVs	n/a
25	rs555180125	chr2:11622952-11622953	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	19 gene(s)	Overlapped CNVs	n/a
26	rs574686861	chr2:11622968-11622969	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	19 gene(s)	Overlapped CNVs	n/a
27	rs542314253	chr2:11622996-11622997	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	19 gene(s)	Overlapped CNVs	n/a
28	rs560998198	chr2:11623058-11623059	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	18 gene(s)	Overlapped CNVs	n/a
29	rs572765541	chr2:11623093-11623094	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	20 gene(s)	Overlapped CNVs	n/a
30	rs540197282	chr2:11623106-11623107	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	20 gene(s)	Overlapped CNVs	n/a
31	rs564703823	chr2:11623158-11623159	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	20 gene(s)	Overlapped CNVs	n/a
32	rs532484433	chr2:11623195-11623196	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	Chromatin interactive region	20 gene(s)	Overlapped CNVs	n/a
33	rs370385132	chr2:11623216-11623217	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	20 gene(s)	Overlapped CNVs	n/a
34	rs533048846	chr2:11623255-11623256	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	20 gene(s)	Overlapped CNVs	n/a
35	rs376795370	chr2:11623273-11623274	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	20 gene(s)	Overlapped CNVs	n/a
36	rs562720260	chr2:11623346-11623347	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	21 gene(s)	Overlapped CNVs	n/a
37	rs143184242	chr2:11623355-11623356	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	21 gene(s)	Overlapped CNVs	n/a
38	rs535666103	chr2:11623360-11623361	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	21 gene(s)	Overlapped CNVs	n/a
39	rs575970873	chr2:11623366-11623367	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	21 gene(s)	Overlapped CNVs	n/a
40	rs544613088	chr2:11623389-11623390	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	21 gene(s)	Overlapped CNVs	n/a
41	rs201669714	chr2:11623398-11623399	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	20 gene(s)	Overlapped CNVs	n/a
42	rs111890351	chr2:11623455-11623456	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	20 gene(s)	Overlapped CNVs	n/a
43	rs148378609	chr2:11623467-11623468	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	17 gene(s)	Overlapped CNVs	n/a
44	rs375518888	chr2:11623468-11623469	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	17 gene(s)	Overlapped CNVs	n/a
45	rs79547196	chr2:11623469-11623470	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	17 gene(s)	Overlapped CNVs	n/a
46	rs386389543	chr2:11623479-11623480	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	17 gene(s)	Overlapped CNVs	n/a
47	rs3071113	chr2:11623480-11623481	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	17 gene(s)	Overlapped CNVs	n/a
48	rs548406480	chr2:11623500-11623501	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	17 gene(s)	Overlapped CNVs	n/a
49	rs185360076	chr2:11623507-11623508	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	17 gene(s)	Overlapped CNVs	n/a
50	rs533962985	chr2:11623540-11623541	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	17 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:61)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Mental retardation	17847001	CNVD
Glioblastoma multiforme	21080181	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Cancer	20164920	CNVD
Neuroblastoma	21508638	CNVD
Breast cancer	17603634	CNVD
Cancer	16751803	CNVD
Neuroblastoma	16790693	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	17393978	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Ewing''s sarcoma	21437220	CNVD
Ependymoma	16718352	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Bladder cancer	21909424	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Glioma	17123091	CNVD
Breast cancer	20409316	CNVD
Multiple myeloma	16616336	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:328 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:11607200-11622400	Weak transcription	Spleen	Spleen
2	chr2:11618200-11622400	Enhancers	HepG2	liver
3	chr2:11618400-11622400	Weak transcription	Psoas Muscle	Psoas
4	chr2:11619200-11622400	Weak transcription	Brain Cingulate Gyrus	brain
5	chr2:11620400-11622800	Enhancers	Fetal Lung	lung
6	chr2:11621000-11622400	Enhancers	Fetal Muscle Leg	muscle
7	chr2:11621200-11622600	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
8	chr2:11621400-11622400	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
9	chr2:11621400-11622400	Bivalent Enhancer	Fetal Stomach	stomach
10	chr2:11621400-11623200	Bivalent Enhancer	Placenta	Placenta
11	chr2:11621400-11623400	Bivalent Enhancer	Fetal Brain Male	brain
12	chr2:11621600-11624000	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
13	chr2:11621800-11622400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
14	chr2:11621800-11622600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
15	chr2:11621800-11622600	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
16	chr2:11621800-11622600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
17	chr2:11621800-11623200	Bivalent Enhancer	Primary B cells from peripheral blood	blood
18	chr2:11621800-11623400	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
19	chr2:11622000-11622400	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
20	chr2:11622000-11622400	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
21	chr2:11622000-11622600	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
22	chr2:11622000-11622600	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
23	chr2:11622000-11622600	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
24	chr2:11622000-11623400	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
25	chr2:11622000-11623400	Bivalent/Poised TSS	Fetal Brain Female	brain
26	chr2:11622000-11623600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
27	chr2:11622000-11624000	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
28	chr2:11622000-11624000	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
29	chr2:11622000-11624600	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
30	chr2:11622000-11624600	Enhancers	Fetal Heart	heart
31	chr2:11622000-11624600	Active TSS	Ovary	ovary
32	chr2:11622200-11622400	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
33	chr2:11622200-11622400	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells	blood
34	chr2:11622200-11622400	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
35	chr2:11622200-11622400	Enhancers	Adipose Nuclei	Adipose
36	chr2:11622200-11622400	Flanking Active TSS	Brain Hippocampus Middle	brain
37	chr2:11622200-11622400	Enhancers	Brain Substantia Nigra	brain
38	chr2:11622200-11622600	Bivalent/Poised TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
39	chr2:11622200-11622600	Flanking Bivalent TSS/Enh	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
40	chr2:11622200-11622600	Flanking Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
41	chr2:11622200-11622600	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
42	chr2:11622200-11622600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr2:11622200-11622600	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
44	chr2:11622200-11622600	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
45	chr2:11622200-11622800	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
46	chr2:11622200-11622800	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
47	chr2:11622200-11622800	Flanking Active TSS	Fetal Muscle Trunk	muscle
48	chr2:11622200-11622800	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
49	chr2:11622200-11623000	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin03	Skin
50	chr2:11622200-11623200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links